Christopher Rhodes to Genetic Therapy
This is a "connection" page, showing publications Christopher Rhodes has written about Genetic Therapy.
Connection Strength
0.436
-
Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes. 2001 Oct; 50(10):2181-91.
Score: 0.175
-
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension. Nat Commun. 2020 03 04; 11(1):1185.
Score: 0.156
-
Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology. 2003 May; 144(5):2016-24.
Score: 0.049
-
Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology. 2009 Oct; 150(10):4502-11.
Score: 0.019
-
Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab. 2005 Dec; 2(6):411-20.
Score: 0.015
-
Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest. 2005 Mar; 115(3):703-10.
Score: 0.014
-
Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab. 2000 Mar; 278(3):E563-9.
Score: 0.010